MZ1 [Ligand Id: 10728] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL4226570
  • bromodomain containing 4/Bromodomain-containing protein 4 in Human [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885]
There should be some charts here, you may need to enable JavaScript!
  • von Hippel-Lindau tumor suppressor/Von Hippel-Lindau disease tumor suppressor in Human [ChEMBL: CHEMBL3108660] [GtoPdb: 3204] [UniProtKB: P40337]
There should be some charts here, you may need to enable JavaScript!
  • von Hippel-Lindau tumor suppressor/Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C in Human [ChEMBL: CHEMBL3301400] [GtoPdb: 3204] [UniProtKB: P40337Q15369Q15370]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
bromodomain containing 4/Bromodomain-containing protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885]
ChEMBL Binding affinity to N-terminal His6-tagged recombinant human Brd4 BD2 expressed in Escherichia coli BL21 (DE3) assessed as compound binary complex formation by isothermal titration calorimetry-based assay B 7.59 pKd 26 nM Kd J Med Chem (2018) 61: 504-513 [PMID:28595007]
GtoPdb Binding affiniy for recombinant human Brd4 BD2 in vitro. - 7.59 pKd 26 nM Kd J Med Chem (2018) 61: 504-513 [PMID:28595007]
von Hippel-Lindau tumor suppressor/Von Hippel-Lindau disease tumor suppressor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3108660] [GtoPdb: 3204] [UniProtKB: P40337]
ChEMBL Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1alpha by binary binding competitive fluorescence polarization assay B 7.47 pKd 34 nM Kd J Med Chem (2021) 64: 18082-18101 [PMID:34881891]
von Hippel-Lindau tumor suppressor/Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3301400] [GtoPdb: 3204] [UniProtKB: P40337Q15369Q15370]
ChEMBL Binding affinity to N-terminal His6-tagged recombinant human VHL (54 to 213 residues)/elongin C (17 to 112 residues)/elongin B (1 to 104 residues) expressed in Escherichia coli BL21 (DE3) assessed as compound binary complex formation by isothermal titration calorimetry-based assay B 7.16 pKd 69 nM Kd J Med Chem (2018) 61: 504-513 [PMID:28595007]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]